Biblio Discovery — Demo Discovery Service

29 hasil untuk "Elham Kayvanpour"

Menampilkan 1–20 · 0,28 detik · RSS

  1. Artikel Jurnal

    Targeting the Sarcomere: Myosin Inhibitors as the Revolutionary Game Changer in Hypertrophic Cardiomyopathy

    Farbod Sedaghat-Hamedani; Elham Kayvanpour; Benjamin Meder

    Reviews in Cardiovascular Medicine, Vol. 27 No. 1 · 2026 · Inggris · DOAJ Scopus

    Hypertrophic cardiomyopathy (HCM) represents the most common inherited cardiac disease and a leading cause of heart failure, arrhythmias, and sudden cardiac death in young individuals. For decades, management of HCM has relied on symptom control with β-blockers, calcium channel blockers…

  2. Artikel Jurnal Teks lengkap

    A Bulking Agent May Lead to Adrenal Insufficiency Crisis: A Case Report

    Seyed Hossein Samadanifard; Farbod Sedaghat-Hamedani; Elham Kayvanpour dkk.

    Acta Medica Iranica, Vol. 49 No. 10 · 2011 · Inggris · DOAJ Scopus

    Adrenal insufficiency is a life-threatening disorder which must be treated with glucocorticoid replacement and needs permanent dose adjustment during patient's different somatic situations. Insufficient glucocorticoid doses result in adrenal crisis and must be treated with intravenous…

  3. Artikel Jurnal

    A Bulking Agent May Lead to Adrenal Insufficiency Crisis: A Case Report

    Salma Ahi; Majid Esmaeilzadeh; Elham Kayvanpour dkk.

    Acta Medica Iranica, Vol. 49 No. 10 · 2011 · Inggris · DOAJ Scopus

    Adrenal insufficiency is a life-threatening disorder which must be treated with glucocorticoid replacement and needs permanent dose adjustment during patient's different somatic situations. Insufficient glucocorticoid doses result in adrenal crisis and must be treated with intravenous…

  4. Artikel Jurnal

    Generation of pluripotent stem cell lines and CRISPR/Cas9 modified isogenic controls from a patient with dilated cardiomyopathy harboring a RBM20 p.R634W mutation

    Sabine Rebs; Farbod Sedaghat-Hamedani; Elham Kayvanpour dkk.

    Stem Cell Research, Vol. 47 · 2020 · Inggris · DOAJ Scopus

    RNA binding motif protein 20 (RBM20) is an alternative splicing factor and highly expressed in cardiac tissue. Mutations in the RS domain of RBM20 have been shown to cause different cardiomyopathies. Here, we generated induced pluripotent stem cells (iPSCs) from a dilated cardiomyopathy patient…

  5. Artikel Jurnal Teks lengkap

    Comparative Assessment of Percutaneous Left-Atrial Appendage Occlusion (LAAO) Devices—A Single Center Cohort Study

    Elham Kayvanpour; Max Kothe; Ziya Kaya dkk.

    Journal of Cardiovascular Development and Disease, Vol. 11 No. 6 · 2024 · Inggris · DOAJ Scopus

    Background: Percutaneous left-atrial appendage closure (LAAC) is an established method for preventing strokes in patients with atrial fibrillation, offering an alternative to oral anticoagulation. Various occluder devices have been developed to cater to individual anatomical needs and ensure a safe…

  6. Artikel Jurnal Teks lengkap

    Multi-omics assessment of dilated cardiomyopathy using non-negative matrix factorization

    Rewati Tappu; Jan Haas; David H. Lehmann dkk.

    PLOS ONE, Vol. 17 No. 8 · 2022 · Inggris · PLOS Scopus

    Dilated cardiomyopathy (DCM), a myocardial disease, is heterogeneous and often results in heart failure and sudden cardiac death. Unavailability of cardiac tissue has hindered the comprehensive exploration of gene regulatory networks and nodal players in DCM. In this study, we carried out…

    Juga tersedia di: DOAJ

  7. Artikel Jurnal

    Generation of an RBM20-mutation-associated left-ventricular non-compaction cardiomyopathy iPSC line (UMGi255-A) into a DCM genetic background to investigate monogenetic cardiomyopathies

    Hanna Eberl; Sabine Rebs; Stefanie Hoppe dkk.

    Stem Cell Research, Vol. 74 · 2024 · Inggris · DOAJ Scopus

    RBM20 mutations account for 3 % of genetic cardiomypathies and manifest with high penetrance and arrhythmogenic effects. Numerous mutations in the conserved RS domain have been described as causing dilated cardiomyopathy (DCM), whereas a particular mutation (p.R634L) drives development of a…

  8. Artikel Jurnal

    Assessing the Applicability of Cardiac Myosin Inhibitors for Hypertrophic Cardiomyopathy Management in a Large Single Center Cohort

    Ali Amr; Elham Kayvanpour; Christoph Reich dkk.

    Reviews in Cardiovascular Medicine, Vol. 25 No. 6 · 2024 · Inggris · DOAJ Scopus

    Background: Cardiac myosin inhibitors (CMIs), including Mavacamten and Aficamten, have emerged as a groundbreaking treatment for hypertrophic cardiomyopathy (HCM). The results from phase 2 and 3 randomized clinical trials for both drugs have showed promising outcomes. However, the highly selective…

  9. Artikel Jurnal Teks lengkap

    Prognostic Value of Circulating Fibrosis Biomarkers in Dilated Cardiomyopathy (DCM): Insights into Clinical Outcomes

    Elham Kayvanpour; Farbod Sedaghat-Hamedani; Daniel Tian Li dkk.

    Biomolecules, Vol. 14 No. 9 · 2024 · Inggris · DOAJ Scopus

    Background: Dilated cardiomyopathy (DCM) involves myocardial remodeling, characterized by significant fibrosis and extracellular matrix expansion. These changes impair heart function, increasing the risk of heart failure and sudden cardiac death. This study investigates the prognostic value of…

  10. Artikel Jurnal

    The Role of Quality Control in Targeted Next-generation Sequencing Library Preparation

    Rouven Nietsch; Jan Haas; Alan Lai dkk.

    Genomics, Proteomics & Bioinformatics, Vol. 14 No. 4 · 2016 · Inggris · DOAJ Scopus

    Next-generation sequencing (NGS) is getting routinely used in the diagnosis of hereditary diseases, such as human cardiomyopathies. Hence, it is of utter importance to secure high quality sequencing data, enabling the identification of disease-relevant mutations or the conclusion of negative test…

  11. Artikel Jurnal

    Predicting sustained ventricular arrhythmias in dilated cardiomyopathy: a meta‐analysis and systematic review

    Arjan Sammani; Elham Kayvanpour; Laurens P. Bosman dkk.

    ESC Heart Failure, Vol. 7 No. 4 · 2020 · Inggris · DOAJ Scopus

    Abstract Aims Patients with non‐ischaemic dilated cardiomyopathy (DCM) are at increased risk of sudden cardiac death. Identification of patients that may benefit from implantable cardioverter‐defibrillator implantation remains challenging. In this study, we aimed to determine predictors of…

  12. Artikel Jurnal

    Personalized care in dilated cardiomyopathy: Rationale and study design of the activeDCM trial

    Farbod Sedaghat‐Hamedani; Ali Amr; Theresa Betz dkk.

    ESC Heart Failure, Vol. 11 No. 6 · 2024 · Inggris · DOAJ Scopus

    Abstract Background Dilated cardiomyopathy (DCM) is a leading cause of heart failure, particularly in younger individuals. Low physical strength is a global risk factor for cardiovascular mortality, and physical activity and a healthy lifestyle have been shown to improve outcomes in patients with…

  13. Artikel Jurnal

    A Remote Patient Monitoring System With Feedback Mechanisms Using a Smartwatch: Concept, Implementation, and Evaluation Based on the activeDCM Randomized Controlled Trial

    Reto Wettstein; Farbod Sedaghat-Hamedani; Oliver Heinze dkk.

    JMIR mHealth and uHealth, Vol. 12 · 2024 · Inggris · DOAJ Scopus

    BackgroundTechnological advances allow for recording and sharing health-related data in a patient-centric way using smartphones and wearables. Secure sharing of such patient-generated data with physicians would enable close management of individual health trajectories, monitoring of risk factors…

  14. Artikel Jurnal Teks lengkap

    Towards Personalized Cardiology: Multi-Scale Modeling of the Failing Heart

    Elham Kayvanpour; Tommaso Mansi; Farbod Sedaghat-Hamedani dkk.

    PLOS ONE, Vol. 10 No. 7 · 2015 · Inggris · PLOS Scopus

    Background: Despite modern pharmacotherapy and advanced implantable cardiac devices, overall prognosis and quality of life of HF patients remain poor. This is in part due to insufficient patient stratification and lack of individualized therapy planning, resulting in less effective treatments and a…

  15. Artikel Jurnal

    Cardiac Myxoma in a Patient With Hypertrophic Cardiomyopathy

    Weng-Tein Gi, MD, MSc; Farbod Sedaghat-Hamedani, MD; Omid Shirvani Samani, MD dkk.

    JACC: Case Reports, Vol. 2 No. 3 · 2020 · Inggris · DOAJ Scopus

    We report a rare case of concomitant hypertrophic cardiomyopathy and cardiac myxoma without LEOPARD syndrome. Additionally, 6 similar cases were systemically reviewed, and the characteristics of this first-ever studied patient group were summarized. (Level of Difficulty: Beginner.)

  16. Artikel Jurnal

    Two Hearts at Risk

    Weng-Tein Gi, MD, MSc; Ali Amr, MD; Farbod Sedaghat-Hamedani, MD dkk.

    JACC: Case Reports, Vol. 2 No. 1 · 2020 · Inggris · DOAJ Scopus

    Hypertrophic obstructive cardiomyopathy (HOCM) increases the risk for mother and fetus during pregnancy. Alcohol septal ablation (ASA) is an established procedure in nonpregnant patients with HOCM. In this report, we present a case of a 29-year-old woman in her 29th gestational week with…

  17. Artikel Jurnal

    The chameleon of cardiology: cardiac sarcoidosis before and after heart transplantation

    Farbod Sedaghat‐Hamedani; Elham Kayvanpour; Sonja Hamed dkk.

    ESC Heart Failure, Vol. 7 No. 2 · 2020 · Inggris · DOAJ Scopus

    Abstract Cardiac sarcoidosis is a chronic inflammatory disease with a large spectrum of symptoms that can mimic diseases such as dilated, hypertrophic, or arrhythmogenic cardiomyopathies. It can be asymptomatic but can also present with ventricular arrhythmias, conduction disease, and heart failure…

  18. Artikel Jurnal

    Current Status of Sodium Bicarbonate in Coronary Angiography: An Updated Comprehensive Meta-Analysis and Systematic Review

    Sadegh Ali-Hassan-Sayegh; Seyed Jalil Mirhosseini; Elham Rahimizadeh dkk.

    Cardiology Research and Practice, Vol. 2015 · 2015 · Inggris · DOAJ Scopus

    This systematic review with meta-analysis sought to determine comparison of efficacy and safety of hydration with sodium bicarbonate versus sodium chloride on contrast induced nephropathy and clinical outcomes. We searched major electronic databases for studies in randomized controlled trials. A…